Join to View Full Profile
10 Rockville PikeBldg 10Bethesda, MD 20892
Phone+1 301-496-8057
Dr. Connors is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Lewis Katz School of Medicine at Temple UniversityClass of 1985, MD
Certifications & Licensure
PA State Medical License 1994 - 2026
MD State Medical License 1989 - 1992
Clinical Trials
- Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy Start of enrollment: 1998 Dec 16
- Intranasal AD4-H5-VTN as an Adenovirus Vaccine Start of enrollment: 2013 Mar 06
- Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers Start of enrollment: 2019 Apr 17
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 2 citationsA multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies.Evan M Cale, Chen-Hsiang Shen, Adam S Olia, Nathan A Radakovich, Reda Rawi
Cell Reports. 2024-12-24 - 10 citationsHIV vaccines induce CD8T cells with low antigen receptor sensitivity.Stephen A Migueles, Danielle M Nettere, Noah V Gavil, Lawrence T Wang, Sushila A Toulmin
Science. 2023-12-15 - 2 citationsApplication of B cell immortalization for the isolation of antibodies and B cell clones from vaccine and infection settings.Kristin L Boswell, Timothy A Watkins, Evan M Cale, Jakob Samsel, Sarah F Andrews
Frontiers in Immunology. 2022-01-01
Grant Support
- Mechanisms of Effective Humoral Immune Responses to HIV-1NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Pre-Clinical Development of Novel Immunotherapies for HIV-1NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Immunity to SARS-CoV-2 After Natural Infection or VaccinationNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNPNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNPNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Immunity to SARS-CoV-2 After Natural Infection or VaccinationNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- Mechanisms of Effective Humoral Immune Responses to HIV-1NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
